Rating Scales for Pain in Parkinson's Disease: Critique and Recommendations

Santiago Perez-Lloret, Daniel Ciampi de Andrade, Kelly E Lyons, Carmen Rodríguez-Blázquez, Kallol Ray Chaudhuri, Guenther Deuschl, Girgio Cruccu, Cristina Sampaio, Christopher G Goetz, Anette Schrag, Pablo Martinez-Martin, Glenn Stebbins, Members of the MDS Committee on Rating Scales Development, Esther Cubo, Deborah Hall, Sheng Luo, Johann Marinus, Laura Marsh, Matej Skorvanek, Santiago Perez-Lloret, Daniel Ciampi de Andrade, Kelly E Lyons, Carmen Rodríguez-Blázquez, Kallol Ray Chaudhuri, Guenther Deuschl, Girgio Cruccu, Cristina Sampaio, Christopher G Goetz, Anette Schrag, Pablo Martinez-Martin, Glenn Stebbins, Members of the MDS Committee on Rating Scales Development, Esther Cubo, Deborah Hall, Sheng Luo, Johann Marinus, Laura Marsh, Matej Skorvanek

Abstract

Background: We aimed at critically appraising the clinimetric properties of existing pain scales or questionnaires and to give recommendations for their use in Parkinson's disease (PD).

Methods: Clinimetric properties of pain scales used in PD were systematically evaluated. A scale was classified as 'recommended' if was used in PD, showed adequate clinimetric properties, and had been used by investigators other than the original developers; as 'suggested' if it was used in PD and fulfilled only one other criterion; and as 'listed' if it was used in PD but did not meet the other criteria. Only scales rating pain intensity or for syndromic classification were assessed.

Results: Eleven of the 34 scales initially considered fulfilled inclusion criteria. Among the scales rating pain intensity, the "Brief Pain Inventory short form," "McGill Pain Questionnaire short and long forms," "Neuropathic Pain Symptoms Inventory," "11-point Numeric Rating Scale," "10-cm Visual Analog Scale," and "Pain-O-Meter" were "recommended with caution" because of lack of clinimetric data in PD, whereas the "King's PD Pain Scale" was "recommended." Among scales for pain syndromic classification, the "DN4" was "recommended with caution" because of lack of clinimetric data in PD; the "Leeds Assessment of Neuropathic Symptoms and Signs," "Pain-DETECT," and the "King's PD Pain Scale" were "suggested."

Conclusions: King's PD pain scale can be recommended for the assessment of pain intensity in PD. Syndromic classification of pain in PD may be achieved by the DN4, but clinimetric data in PD are needed for this scale.

Keywords: Pain; Parkinson's disease; clinical trials; clinimetric assessment; epidemiology; rating scales.

References

    1. Parkinson J. An essay on the shaking palsy. 1817. J Neuropsychiatry Clin Neurosci 2002;14:223–236; discussion, 222.
    1. Chaudhuri KR, Schapira AH. Non‐motor symptoms of Parkinson's disease: dopaminergic pathophysiology and treatment. Lancet Neurol 2009;8:464–474.
    1. Negre‐Pages L, Regragui W, Bouhassira D, Grandjean H, Rascol O. Chronic pain in Parkinson's disease: the cross‐sectional French DoPaMiP survey. Mov Disord 2008;23:1361–1369.
    1. Broen MP, Braaksma MM, Patijn J, Weber WE. Prevalence of pain in Parkinson's disease: a systematic review using the modified QUADAS tool. Mov Disord 2012;27:480–484.
    1. Juniper M, Le TK, Mladsi D. The epidemiology, economic burden, and pharmacological treatment of chronic low back pain in France, Germany, Italy, Spain and the UK: a literature‐based review. Expert Opin Pharmacother 2009;10:2581–2592.
    1. Sa KN, Baptista AF, Matos MA, Lessa I. Chronic pain and gender in Salvador population, Brazil. Pain 2008;139:498–506.
    1. Ford B. Pain in Parkinson's disease. Mov Disord 2010;25(Suppl 1):S98–S103.
    1. Wasner G, Deuschl G. Pains in Parkinson disease—many syndromes under one umbrella. Nat Rev Neurol 2012;8:284–294.
    1. International Association for the Study of Pain Subcommittee on Taxonomy. Classification of chronic pain: descriptions of chronic pain syndromes and definitions of pain terms. Pain 1986;24 Suppl 1:S1–S226.
    1. Breivik H, Borchgrevink PC, Allen SM, et al. Assessment of pain. Br J Anaesth 2008;101:17–24.
    1. Sampaio C, Goetz C, Schrag A, eds. Rating Scales in Parkinson's Disease: clinical Practice and Research. New York: Oxford University Press; 2012.
    1. Cleeland C. Measurement of pain by subjective report In: Chapman CR, Loeser JD, eds. Issues in Pain Measurement, 1st ed New York: Raven; 1989:391–403.
    1. Cleeland CS, Ryan KM. Pain assessment: global use of the Brief Pain Inventory. Ann Acad Med Singapore 1994;23:129–138.
    1. Tan G, Jensen MP, Thornby JI, Shanti BF. Validation of the Brief Pain Inventory for chronic nonmalignant pain. J Pain 2004;5:133–137.
    1. Daut RL, Cleeland CS, Flanery RC. Development of the Wisconsin Brief Pain Questionnaire to assess pain in cancer and other diseases. Pain 1983;17:197–210.
    1. Mendoza T, Mayne T, Rublee D, Cleeland C. Reliability and validity of a modified Brief Pain Inventory short form in patients with osteoarthritis. Eur J Pain 2006;10:353–361.
    1. Mendoza TR, Chen C, Brugger A, et al. The utility and validity of the modified brief pain inventory in a multiple‐dose postoperative analgesic trial. Clin J Pain 2004;20:357–362.
    1. Keller S, Bann CM, Dodd SL, Schein J, Mendoza TR, Cleeland CS. Validity of the brief pain inventory for use in documenting the outcomes of patients with noncancer pain. Clin J Pain 2004;20:309–318.
    1. Tittle MB, McMillan SC, Hagan S. Validating the brief pain inventory for use with surgical patients with cancer. Oncol Nurs Forum 2003;30:325–330.
    1. Beiske AG, Loge JH, Ronningen A, Svensson E. Pain in Parkinson's disease: Prevalence and characteristics. Pain 2009;141:173–177.
    1. Ciampi de Andrade D, Lefaucheur JP, Galhardoni R, et al. Subthalamic deep brain stimulation modulates small fiber‐dependent sensory thresholds in Parkinson's disease. Pain 2012;153:1107–1113.
    1. Djaldetti R, Yust‐Katz S, Kolianov V, Melamed E, Dabby R. The effect of duloxetine on primary pain symptoms in Parkinson disease. Clin Neuropharmacol 2007;30:201–205.
    1. Lee MA, Walker RW, Hildreth TJ, Prentice WM. A survey of pain in idiopathic Parkinson's disease. J Pain Symptom Manage 2006;32:462–469.
    1. Rana AQ, Siddiqui I, Mosabbir A, et al. Association of pain, Parkinson's disease, and restless legs syndrome. J Neurol Sci 2013;327:32–34.
    1. Lin XJ, Yu N, Lin XG, et al. A clinical survey of pain in Parkinson's disease in Eastern China. Int Psychogeriatr 2016;28:283–289.
    1. Madeo G, Schirinzi T, Natoli S, et al. Efficacy and safety profile of prolonged release oxycodone in combination with naloxone (OXN PR) in Parkinson's disease patients with chronic pain. J Neurol 2015;262:2164–2170.
    1. Rana AQ, Qureshi AR, Mumtaz A, et al. Associations of pain and depression with marital status in patients diagnosed with Parkinson's disease. Acta Neurol Scand 2016;133:276–280.
    1. Bouhassira D, Attal N, Alchaar H, et al. Comparison of pain syndromes associated with nervous or somatic lesions and development of a new neuropathic pain diagnostic questionnaire (DN4). Pain 2005;114:29–36.
    1. Attal N, Perrot S, Fermanian J, Bouhassira D. The neuropathic components of chronic low back pain: a prospective multicenter study using the DN4 Questionnaire. J Pain 2011;12:1080–1087.
    1. Haanpaa M, Attal N, Backonja M, et al. NeuPSIG guidelines on neuropathic pain assessment. Pain 2011;152:14–27.
    1. Chaudhuri RK, Rizos A, Trenkwalder C, et al. EUROPAR and the IPMDS Non Motor PD Study Group. King's Parkinson's Disease Pain Scale, the first scale for pain in PD: an international validation. Mov Disord 2015;30:1623–1631.
    1. Rascol O, Zesiewicz T, Chaudhuri KR, et al. A randomized controlled exploratory pilot study to evaluate the effect of rotigotine transdermal patch on Parkinson's disease‐associated chronic pain. J Clin Pharmacol 2015. doi: 10.1002/jcph.678. [Epub ahead of print]
    1. Trenkwalder C, Chaudhuri KR, Martinez‐Martin P, et al. Prolonged‐release oxycodone‐naloxone for treatment of severe pain in patients with Parkinson's disease (PANDA): a double‐blind, randomised, placebo‐controlled trial. Lancet Neurol 2015;14:1161–1170.
    1. Bennett M. The LANSS Pain Scale: the Leeds assessment of neuropathic symptoms and signs. Pain 2001;92:147–157.
    1. Hanagasi HA, Akat S, Gurvit H, Yazici J, Emre M. Pain is common in Parkinson's disease. Clin Neurol Neurosurg 2011;113:11–13.
    1. Melzack R. The McGill Pain Questionnaire: major properties and scoring methods. Pain 1975;1:277–299.
    1. Graham C, Bond SS, Gerkovich MM, Cook MR. Use of the McGill pain questionnaire in the assessment of cancer pain: replicability and consistency. Pain 1980;8:377–387.
    1. Katz J, Melzack R. The McGill Pain Questionnaire: development, psychometric properties and usefulness of the long form, short form and short form‐2 In: Turk DC, Melzack R, eds. Handbook of Pain Assessment, 3rd ed New York: Guilford; 2011:45–67.
    1. Ahles TA, Ruckdeschel JC, Blanchard EB. Cancer‐related pain—II. Assessment with visual analogue scales. J Psychosom Res 1984;28:121–124.
    1. Elton D, Burrows GD, Stanley GV. Clinical measurement of pain. Med J Aust 1979;1:109–111.
    1. Dubuisson D, Melzack R. Classification of clinical pain descriptions by multiple group discriminant analysis. Exp Neurol 1976;51:480–487.
    1. Lim SY, Farrell MJ, Evans AH. Parkinson's disease and pain—nondopaminergic mechanisms are likely to be important too. Mov Disord 2011;26:1353–1354.
    1. Lim SY, Farrell MJ, Gibson SJ, Helme RD, Lang AE, Evans AH. Do dyskinesia and pain share common pathophysiological mechanisms in Parkinson's disease? Mov Disord 2008;23:1689–1695.
    1. Page DB, Weaver F, Wilkie DJ, Simuni T. A computerized survey of pain in Parkinson's disease patients: a pilot feasibility study. Parkinsonism Relat Disord 2010;16:139–141.
    1. Melzack R. The short‐form McGill Pain Questionnaire. Pain 1987;30:191–197.
    1. Wright KD, Asmundson GJ, McCreary DR. Factorial validity of the short‐form McGill pain questionnaire (SF‐MPQ). Eur J Pain 2001;5:279–284.
    1. Zalon ML. Comparison of pain measures in surgical patients. J Nurs Meas 1999;7:135–152.
    1. Grafton KV, Foster NE, Wright CC. Test‐retest reliability of the Short‐Form McGill Pain Questionnaire: assessment of intraclass correlation coefficients and limits of agreement in patients with osteoarthritis. Clin J Pain 2005;21:73–82.
    1. Kass‐Iliyya L, Kobylecki C, McDonald KR, Gerhard A, Silverdale MA. Pain in multiple system atrophy and progressive supranuclear palsy compared to Parkinson's disease. Brain Behav 2015;5:e00320.
    1. Pellaprat J, Ory‐Magne F, Canivet C, et al. Deep brain stimulation of the subthalamic nucleus improves pain in Parkinson's disease. Parkinsonism Relat Disord 2014;20:662–664.
    1. McNamara P, Stavitsky K, Harris E, Szent‐Imrey O, Durso R. Mood, side of motor symptom onset and pain complaints in Parkinson's disease. Int J Geriatr Psychiatry 2010;25:519–524.
    1. Bouhassira D, Attal N, Fermanian J, et al. Development and validation of the Neuropathic Pain Symptom Inventory. Pain 2004;108:248–257.
    1. Attal N, Fermanian C, Fermanian J, Lanteri‐Minet M, Alchaar H, Bouhassira D. Neuropathic pain: are there distinct subtypes depending on the aetiology or anatomical lesion? Pain 2008;138:343–353.
    1. Kim HJ, Paek SH, Kim JY, et al. Chronic subthalamic deep brain stimulation improves pain in Parkinson disease. J Neurol 2008;255:1889–1894.
    1. DeLoach LJ, Higgins MS, Caplan AB, Stiff JL. The visual analog scale in the immediate postoperative period: intrasubject variability and correlation with a numeric scale. Anesth Analg 1998;86:102–106.
    1. Gallagher EJ, Bijur PE, Latimer C, Silver W. Reliability and validity of a visual analog scale for acute abdominal pain in the ED. Am J Emerg Med 2002;20:287–290.
    1. Jensen MP, Chen C, Brugger AM. Interpretation of visual analog scale ratings and change scores: a reanalysis of two clinical trials of postoperative pain. J Pain 2003;4:407–414.
    1. Jones KR, Vojir CP, Hutt E, Fink R. Determining mild, moderate, and severe pain equivalency across pain‐intensity tools in nursing home residents. J Rehabil Res Dev 2007;44:305–314.
    1. Wood BM, Nicholas MK, Blyth F, Asghari A, Gibson S. Assessing pain in older people with persistent pain: the NRS is valid but only provides part of the picture. J Pain 2010;11:1259–1266.
    1. Bijur PE, Latimer CT, Gallagher EJ. Validation of a verbally administered numerical rating scale of acute pain for use in the emergency department. Acad Emerg Med 2003;10:390–392.
    1. Ferreira‐Valente MA, Pais‐Ribeiro JL, Jensen MP. Validity of four pain intensity rating scales. Pain 2011;152:2399–2404.
    1. Broetz D, Eichner M, Gasser T, Weller M, Steinbach JP. Radicular and nonradicular back pain in Parkinson's disease: a controlled study. Mov Disord 2007;22:853–856.
    1. Granovsky Y, Schlesinger I, Fadel S, Erikh I, Sprecher E, Yarnitsky D. Asymmetric pain processing in Parkinson's disease. Eur J Neurol 2013;20:1375–1382.
    1. Muller T, Muhlack S, Woitalla D. Pain perception, pain drug therapy and health status in patients with Parkinson's disease. Neuroepidemiology 2011;37:183–187.
    1. Oshima H, Katayama Y, Morishita T, et al. Subthalamic nucleus stimulation for attenuation of pain related to Parkinson disease. J Neurosurg 2012;116:99–106.
    1. Quittenbaum BH, Grahn B. Quality of life and pain in Parkinson's disease: a controlled cross‐sectional study. Parkinsonism Relat Disord 2004;10:129–136.
    1. Rintala DH, Tan G, Willson P, Bryant MS, Lai EC. Feasibility of using cranial electrotherapy stimulation for pain in persons with Parkinson's disease. Parkinsons Dis 2010;2010:569154.
    1. Tinazzi M, Del VC, Fincati E, et al. Pain and motor complications in Parkinson's disease. J Neurol Neurosurg Psychiatry 2006;77:822–825.
    1. Vallderiola F, Compta Y, Aparicio J, et al. Effects of night‐time use of rotigotine on nocturnal symptoms in Parkinson's disease. Parkinsons Dis 2015;2015:475630.
    1. Dworkin RH, Turk DC, Farrar JT, et al. Core outcome measures for chronic pain clinical trials: IMMPACT recommendations. Pain 2005;113:9–19.
    1. Freynhagen R, Baron R, Gockel U, Tolle TR. painDETECT: a new screening questionnaire to identify neuropathic components in patients with back pain. Curr Med Res Opin 2006;22:1911–1920.
    1. Gudbergsen H, Bartels EM, Krusager P, et al. Test‐retest of computerized health status questionnaires frequently used in the monitoring of knee osteoarthritis: a randomized crossover trial. BMC Musculoskelet Disord 2011;12:190.
    1. Gierthmuhlen J, Arning P, Binder A, et al. Influence of deep brain stimulation and levodopa on sensory signs in Parkinson's disease. Mov Disord 2010;25:1195–1202.
    1. Gaston‐Johansson F. Measurement of pain: the psychometric properties of the Pain‐O‐Meter, a simple, inexpensive pain assessment tool that could change health care practices. J Pain Symptom Manage 1996;12:172–181.
    1. Ekdahl L, Petersson K. Acupuncture treatment of pregnant women with low back and pelvic pain—an intervention study. Scand J Caring Sci 2010;24:175–182.
    1. Skogar O, Fall PA, Hallgren G, et al. Parkinson's disease patients’ subjective descriptions of characteristics of chronic pain, sleeping patterns and health‐related quality of life. Neuropsychiatr Dis Treat 2012;8:435–442.
    1. Mylius V, Ciampi de Andrade D, Cury RG, et al. Pain in Parkinson's disease: current concepts and a new diagnostic algorithm. Mov Disord Clin Pract 2015;2:357–364.

Source: PubMed

Sponsor e collaboratori

Condizioni mediche

Interventi farmacologici

3
Sottoscrivi